Skip to main content
Log in

Hyponatraemia in a Patient Treated with Bromocriptine

  • Case Report
  • Published:
Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Begaud B, Evreux J, Jouglard J, Lagier G. Unexpected or toxic drug reaction assessment (Imputation). Actualization of the method used in France. Thérapie 40: 111–118, 1985

    PubMed  CAS  Google Scholar 

  • Bello-Reuss E, Higashi Y, Kaneda Y. Dopamine decrease fluid reabsorption in straight portions of rabbit proximal tubule. American Journal of Physiology 242: 634–640, 1982

    Google Scholar 

  • Bogaert M, Buylaert W, Lefebvre R, Willems J. Récepteurs dopaminergiques périphériques. Actualités Pharmacologiques 33: 57–75, 1980

    Google Scholar 

  • Damase-Michel C, Montastruc JL, Tran MA, Gharib C, Geelen G, et al. Involvement of vasopressin in the cardiovascular effects of quinpirole. European Journal of Pharmacology 184: 179–183, 1990

    Article  PubMed  CAS  Google Scholar 

  • Horrobin DF. Prolactin as a regulator of fluid and electrolyte metabolism in mammals. Federation Proceedings 39: 2567–2570, 1980

    PubMed  CAS  Google Scholar 

  • Lokhandwala MF, Hedge SS. Cardiovascular dopamine receptors: Role of renal dopamine and dopamine receptors in sodium excretion. Pharmacology and Toxicology 66: 237–243, 1990

    Article  PubMed  CAS  Google Scholar 

  • Marschall AW, Jakobovits AW, Morgan MY. Bromocriptine-associated hyponatraemia in cirrhosis. British Medical Journal 285: 1534, 1982

    Article  Google Scholar 

  • McDonald RH, Goldberg LI, McNay JL, Tuttle EP. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. Journal of Clinical Investigation 43: 1116, 1964

    Article  PubMed  CAS  Google Scholar 

  • Montastruc JL, Montastruc P. Alpha-adrenolytic properties of bromocriptine. Archives Internationales de Pharmacodynamie et de Therapie 260: 83–90, 1982

    PubMed  CAS  Google Scholar 

  • Moses A, Miller M. Drug induced dilutional hyponatremia. New England Journal of Medicine 5: 1234–1239, 1974

    Article  Google Scholar 

  • Nagahama S, Ann HS, Chen Y, Linheimer MD, Oparil S. Role of vasopressin in the cardiovascular effects of LY 171555, a selective D2 receptor agonist; studies in conscious Brattleboro and Long-Evans rats. Journal of Pharmacological and Experimental Therapeutics 242: 143, 1987

    CAS  Google Scholar 

  • Pettinger WA, Umemura S, Smyth D, Jeffries W. Renal α2-adrenoceptors and the adenylate cyclase-cAMP system: biochemical and physiological interactions. American Journal of Physiology 252: 199–208, 1987

    Google Scholar 

  • Robinson EG, Clifton-Bligh P, Posen S, Morris BJ. The effect of bromocriptine on circulating vasopressin. Clinical Science 63: 367–372, 1982

    PubMed  CAS  Google Scholar 

  • Seri I. Dopamine and natriuresis mechanism of action and developmental aspects. American Journal of Hypertension 3: 82–86, 1990

    Google Scholar 

  • Smyth D, Pettinger WA, Umemura S. Renal nerve stimulation causes α1-adrenoceptor mediated sodium retention but no α2-adrenoceptor antagonism of vasopressin. Circulation Research 57: 304–311, 1985

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damase-Michel, C., Sarrail, E., Laens, J. et al. Hyponatraemia in a Patient Treated with Bromocriptine. Drug Invest. 5, 285–287 (1993). https://doi.org/10.1007/BF03259594

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259594

Keywords

Navigation